PRDX5 and lung carcinoma: In line with this, in humans, an increase in the centromeric αSat and HSat3 transcripts was detected in a study that encompasses the knockdown of peroxiredoxin-5 (PRDX5), an antioxidant protein that neutralizes ROS in human lung cancer cells [57].